-0.36% to Target, Jefferies Reaffirms “Hold” Rating for Renasant (RNST) Stock; Last Week Tetraphase Pharmaceuticals (TTPH) Analysts

June 9, 2017 - By Vivian Currie

Among 5 analysts covering Renasant (NASDAQ:RNST), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Renasant has $4300 highest and $38 lowest target. $39.67’s average target is -10.17% below currents $44.16 stock price. Renasant had 9 analyst reports since October 22, 2015 according to SRatingsIntel. The firm has “Long-Term Buy” rating given on Thursday, January 21 by Hilliard Lyons. The company was upgraded on Thursday, April 28 by Hilliard Lyons. As per Tuesday, November 29, the company rating was downgraded by Keefe Bruyette & Woods. The rating was downgraded by Raymond James to “Outperform” on Monday, September 12. Keefe Bruyette & Woods maintained Renasant Corp. (NASDAQ:RNST) rating on Friday, May 26. Keefe Bruyette & Woods has “Hold” rating and $4300 target. The rating was downgraded by Stephens on Thursday, October 22 to “Equal Weight”. The firm has “Hold” rating given on Monday, November 28 by Jefferies.

Among 11 analysts covering Tetraphase Pharmaceuticals (NASDAQ:TTPH), 2 have Buy rating, 0 Sell and 9 Hold. Therefore 18% are positive. Tetraphase Pharmaceuticals had 16 analyst reports since August 6, 2015 according to SRatingsIntel. Brean Capital maintained Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) rating on Thursday, August 6. Brean Capital has “Buy” rating and $51 target. On Wednesday, September 9 the stock rating was downgraded by Stifel Nicolaus to “Hold”. The stock of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) earned “Neutral” rating by SunTrust on Wednesday, September 9. Wedbush downgraded the shares of TTPH in report on Wednesday, September 9 to “Neutral” rating. The firm earned “Market Perform” rating on Tuesday, April 12 by BMO Capital Markets. The firm has “Buy” rating given on Thursday, August 6 by Stifel Nicolaus. The rating was downgraded by JMP Securities to “Market Perform” on Wednesday, September 9. The stock has “Hold” rating by Cantor Fitzgerald on Wednesday, September 9. The stock has “Outperform” rating by BMO Capital Markets on Friday, March 10. The stock of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) earned “Hold” rating by Brean Capital on Wednesday, September 9. See Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) latest ratings:

10/03/2017 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Outperform Old Target: $6.00 New Target: $10.00 Upgrade

Investors sentiment increased to 1.29 in Q4 2016. Its up 0.17, from 1.12 in 2016Q3. It improved, as 12 investors sold Tetraphase Pharmaceuticals Inc shares while 22 reduced holdings. 12 funds opened positions while 32 raised stakes. 17.45 million shares or 11.89% less from 19.80 million shares in 2016Q3 were reported. Morgan Stanley holds 149,798 shares. Loring Wolcott And Coolidge Fiduciary Ltd Liability Partnership Ma holds 3,600 shares or 0% of its portfolio. California Employees Retirement Sys holds 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) for 224,700 shares. 157,429 were reported by Millennium Llc. Credit Suisse Ag stated it has 23,327 shares. Legal And General Gru Public Lc reported 12,301 shares or 0% of all its holdings. Manchester Mngmt Limited Company owns 0.01% invested in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) for 14,984 shares. Gru One Trading Ltd Partnership reported 1,018 shares. Federated Investors Pa invested 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Meeder Asset Mngmt has invested 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Citigroup reported 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). The Connecticut-based Tudor Inv Et Al has invested 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Rock Springs Cap Management L P invested 0.19% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). D E Shaw & Company Inc owns 164,062 shares for 0% of their portfolio. Oxford Asset Management owns 0% invested in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) for 22,301 shares.

Since March 15, 2017, it had 1 insider buy, and 0 sales for $82,370 activity. On Wednesday, March 15 GAGE L PATRICK bought $82,370 worth of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) or 11,000 shares.

It closed at $7.32 lastly. It is down 106.58% since June 9, 2016 and is uptrending. It has outperformed by 89.88% the S&P500.

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $278.22 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It currently has negative earnings. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

The stock increased 3.08% or $1.32 during the last trading session, reaching $44.16. About 302,667 shares traded or 88.83% up from the average. Renasant Corp. (NASDAQ:RNST) has risen 22.29% since June 9, 2016 and is uptrending. It has outperformed by 5.59% the S&P500.

Renasant Corporation is a bank holding firm that owns and operates Renasant Bank and Renasant Insurance, Inc. (Renasant Insurance). The company has market cap of $2.03 billion. The Company’s divisions include Community Banks, which delivers a range of banking and financial services to individuals and small to medium-sized businesses, including checking and savings accounts, business and personal loans, equipment leasing, as well as safe deposit and night depository facilities; Insurance, which includes a full service insurance agency offering all lines of commercial and personal insurance through major carriers; Wealth Management, which offers a range of fiduciary services that includes the administration and management of trust accounts, including personal and corporate benefit accounts, and custodial accounts, and Other. It has a 20.25 P/E ratio. The Bank has its activities in Mississippi, Tennessee, Alabama, Florida and Georgia.